HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Woolly Monkey Sarcoma Virus

Woolly Monkey Sarcoma Virus (WMSV) is a retrovirus that primarily affects woolly monkeys, a species native to the Amazon rainforest. This virus belongs to the family Retroviridae and is closely related to other primate retroviruses. WMSV is known for its ability to induce sarcomas, which are malignant tumors arising from connective tissues such as bone, cartilage, and muscle. Discovered in the mid-20th century, Woolly Monkey Sarcoma Virus has been extensively studied to understand its virology and the mechanisms underlying its oncogenic properties. The virus is transmitted through bodily fluids, and infection can lead to the development of sarcomas in various organs and tissues of infected monkeys. The genome of WMSV contains genetic information that allows it to integrate into the host's DNA, leading to the dysregulation of cellular processes and the initiation of tumor formation. The virus's oncogenic potential has made it a valuable model for studying the molecular mechanisms of cancer development. While WMSV primarily affects woolly monkeys, there is no evidence to suggest that it poses a significant threat to human health. Nevertheless, research on this virus has provided valuable insights into retroviral oncogenesis and has contributed to our broader understanding of cancer biology. Ongoing studies continue to explore the intricate interactions between Woolly Monkey Sarcoma Virus and its host, shedding light on potential therapeutic strategies for retrovirus-associated cancers.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp